#KeystoneSymposium

Researchers from around the world headed to Santa Fe for long COVID conference A few years have passed since the height of the COVID-19 pandemic, but but researchers estimate millions of people are still living with the effects of long COVID. The Keystone Symposia on ‘Long COVID...

#Apresj20 #CovidLong #LongCovid #KeystoneSymposium #SantéPublique

www.kunm.org/local-news/2...

🧵Santa Fe accueille la conférence mondiale #CovidLong #KeystoneSymposium

Long COVID and Other Post-Acute Infection Syndromes | Keystone Symposia Join us at the Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes, August 2025, in Santa Fe, with field leaders!

#Apresj20 #LongCovid #KeystoneSymposium #SantéPublique #Recherche

www.keystonesymposia.org/conferences/...

Delighted to be able to present my PhD findings of bNAb in gut tissue, alongside the primary RIO trial findings at the Keystone HIV cure symposium in Durban!

#KeystoneSymposium #HIVcure2025

Chart showing 3 patterns of viral rebound in people in the RIO study

People who receive bNAbs respond differently, some experience delayed rebound beyond 20 weeks after one dose, and some do not rebound at all. However some people still experienced early rebound despite being screened for predicted bNAb resistance.

#KeystoneSymposium #HIVcure2025

Ming Lee presenting his conference talk titled 'The use of long-acting broadly neutralising antibodies to confer HIV viral control'

Dr Ming Lee, RIO trial physician @drmjlee.bsky.social presents the primary findings from RIO and his gut sub-study at the Keystone HIV cure conference in Durban, S. Africa.

#KeystoneSymposium #HIVcure

Honored to be invited as a speaker at the upcoming #KeystoneSymposium on MASH Pathogenesis and Therapeutic Approaches! I’ll be discussing opportunities and challenges in screening for liver disease in type 2 diabetes.

It's a fantastic program—a must-attend for anyone interested in #MASLD!